NRG-BR002 Published in JCO
For Breast Cancer Awareness Month, we discuss the results of the NRG-BR002 in newly oligometastatic breast cancer published in the Journal of Clinical Oncology today.
7 Loka 13min
NRG-HN009 p16-Negative Results at ASTRO 2026
We discuss the reported results of the NRG-HN009 p16-negative cohort presented at the ASTRO Annual Meeting Late-Breaking Abstract Session.
29 Syys 13min
NRG-CC009 and the MAVERICK Study at ASTRO 2026
We discuss both the NRG-CC009 study results presented during the 2026 ASTRO Annual Meeting Plenary Session and the MAVERICK study results presented during the Clinical Trials Session.
28 Syys 21min
NRG-GI003 Results in the ASTRO 2026 Plenary
We discuss the NRG-GI003 results presented during the 2026 ASTRO Annual Meeting Plenary Session.
28 Syys 14min
The NRG-GY036 Trial for Ovarian Cancer Month
For the 2026 Ovarian Cancer Month & Gynecologic Cancer Month, we discuss the currently enrolling NRG-GY036 clinical trial comparing 1 vs. 2 years of maintenance olaparib (with or without bevacizumab) ...
4 Syys 23min
NRG-HN016: The "CONCISE" Study for Locoregionally Advanced Head and Neck Cancer Patients that are Unable to Take Cisplatin
Our co-hosts interview the PI of the active NRG-HN016 (CONCISE) trial, Dr. Loren Mell. The CONCISE study is a randomized phase III trial comparing radiation therapy (RT) plus carboplatin/paclitaxel vs...
13 Elo 17min
NRG-GU015, the "ARCHER" Study for Muscle Invasive Bladder Cancer
Our co-hosts welcome Dr. Scott Delacroix and Dr. Himanshu Nagar to discuss bladder cancer, bladder preservation, and the newly activated NRG-GU015 (ARCHER) clinical trial. In this episode, the experts...
30 Heinä 28min
